Reversal of Multidrug Resistance by the Chinese Medicine Yiqi Jianpi Huaji Decoction and the Mechanism of Action in Human Gastric Cancer SGC7901/VCR Cells

Weibing Li, Yang Li, Yu Chen, Yong‐Ming HeEvidence-based Complementary and Alternative Medicine 2015 · DOI

TL;DR

This study investigates how a traditional Chinese medicine formula, Yiqi Jianpi Huaji Decoction (YJHD), can reverse multidrug resistance (MDR) in human gastric cancer cells. YJHD was found to inhibit cancer cell proliferation, induce apoptosis, and significantly enhance the sensitivity of resistant cells to common chemotherapy drugs like vincristine and 5-fluorouracil by downregulating key drug resistance genes.

What Problem Does This Paper Address?

Gastric cancer remains a significant global health challenge, with high mortality rates, particularly in China. A major hurdle in treating gastric cancer is the development of multidrug resistance (MDR) in cancer cells. This resistance often arises from the overexpression of specific proteins, such as P-glycoprotein (P-gp) and multidrug resistance-associated protein (MRP), which actively pump chemotherapy drugs out of the cells. Additionally, alterations in other genes like TUBB3, STMN1, and TS can also contribute to treatment failure. The paper addresses the critical need for novel strategies to overcome MDR and improve the efficacy of existing chemotherapy treatments.

Methods

The researchers employed a multi-pronged approach to investigate YJHD's effects:

  • Cell Viability Assays (CCK-8): This standard assay was used to measure the impact of YJHD and chemotherapy drugs (vincristine and 5-fluorouracil) on cancer cell proliferation, both individually and in combination.
  • Flow Cytometry: Used to quantify apoptosis (programmed cell death) induced by YJHD and chemotherapy treatments.
  • Cell Cycle Analysis: This technique was used to determine how YJHD and chemotherapy affect the progression of cancer cells through their life cycle, specifically looking for cell cycle arrest.
  • Real-Time Reverse Transcriptase-PCR (RT-PCR): This method was used to measure the mRNA levels of genes associated with drug resistance (MDR1, MRP, TUBB3, STMN1, and TS) to understand how YJHD influences their expression.
  • Western Blot Analysis: This technique was used to detect and quantify the protein levels of the same drug resistance genes, confirming the mRNA findings at the protein level.
  • RNA Interference (RNAi) with siRNAs: Short interfering RNAs (siRNAs) were used to specifically "knock down" or silence the expression of key drug resistance genes (MDR1, MRP, TUBB3, and STMN1). This allowed the researchers to directly assess the role of these genes in drug resistance.

Datasets

Not discussed in the paper. The study utilized established human gastric cancer cell lines (SGC7901 and SGC7901/VCR) and standard laboratory reagents.

Key Insights and Ideas

  • YJHD as a Potent MDR Reverser: The study provides strong evidence that YJHD can significantly re-sensitize multidrug-resistant gastric cancer cells to conventional chemotherapy. This is a crucial finding for developing more effective treatment regimens.
  • Targeting Multiple Resistance Mechanisms: YJHD appears to act on multiple fronts, not only by downregulating the primary efflux pumps (P-gp, MRP) but also by affecting genes involved in microtubule dynamics (TUBB3, STMN1). This broad-spectrum action might explain its effectiveness.
  • Synergistic Effects with Chemotherapy: The combination of a low, non-toxic dose of YJHD with chemotherapy drugs demonstrated a synergistic effect, leading to greater cell death and apoptosis than either treatment alone.
  • RNAi Confirms Gene Targets: The use of siRNA to silence specific resistance genes directly validated the findings from YJHD treatment, confirming that the downregulation of MDR1, MRP, TUBB3, and STMN1 is indeed responsible for reversing drug resistance.
  • TS Expression Unaffected: Interestingly, YJHD did not significantly alter the expression of Thymidylate Synthase (TS), suggesting that its primary mechanism of action in this context doesn't involve this specific target, unlike some other resistance pathways.

Key Results

  • YJHD dose-dependently inhibited the proliferation of SGC7901/VCR cells and induced apoptosis.
  • A low dose of YJHD (0.5 mg/mL) significantly increased the sensitivity of SGC7901/VCR cells to vincristine and 5-fluorouracil, reducing their IC50 values by approximately 2.33-fold and 2.99-fold, respectively.
  • YJHD treatment led to a significant downregulation of mRNA and protein expression of MDR1 (P-gp), MRP, TUBB3, and STMN1 in SGC7901/VCR cells.
  • Knocking down these genes using siRNAs also significantly reversed drug resistance and increased sensitivity to vincristine.
  • YJHD, when combined with 5-Fu, enhanced 5-Fu-induced S-phase arrest in SGC7901/VCR cells.

Limitations and Future Work

  • In Vitro Study: The findings are based on in vitro experiments using cell lines. Further validation in animal models and ultimately in human clinical trials is necessary to confirm these promising results.
  • Complexity of MDR: While YJHD showed effects on several key genes, the paper acknowledges that MDR is a complex phenomenon with potentially other contributing factors that were not fully explored.
  • Specific Components of YJHD: The study used the whole YJHD formula. Identifying the specific active components within the twelve-ingredient mixture responsible for these effects could lead to more targeted drug development.
  • Clinical Application: The authors suggest that YJHD could be a valuable chemosensitizer or adjuvant for gastric cancer treatment, but emphasize that clinical application requires further evaluation. They also propose exploring RNAi strategies for cancer treatment.

Summary updated

Abstract

Yiqi Jianpi Huaji Decoction (YJHD), a traditional Chinese medicinal formula composed of twelve ingredients, has recently been reported to have a good clinical curative effect. The purpose of the present study was to evaluate the effects of YJHD on SGC7901/VCR gastric cancer cells and to elucidate the possible mechanism of action. First, the effects of a low dose of YJHD in combination with chemotherapeutic agents on SGC7901/VCR cells were assessed using the CCK-8 assay and flow cytometry, and the effects of YJHD on genes and proteins involved in drug resistance (MDR1, MRP, TUBB3, STMN1, and TS) were evaluated. Furthermore, transfection of SGC7901/VCR cells with siRNAs targeting these genes inhibited their expression, and the efficacy of vincristine against the cells was dramatically improved in vitro when these genes were silenced. These results demonstrate that low-dose YJHD inhibited cell proliferation, induced apoptosis, reversed MDR, and increased sensitivity to chemotherapeutic agents in vitro by downregulating P-gp, MRP, TUBB3, and STMN1 expression. MDR can be reversed by siRNAs targeting genes involved in MDR, and this strategy for cancer treatment should be evaluated in future studies.
BibTeX
@inproceedings{li2015reversal,
  author = {Weibing Li and Yang Li and Yu Chen and Yong‐Ming He},
  title = {{Reversal of Multidrug Resistance by the Chinese Medicine Yiqi Jianpi Huaji Decoction and the Mechanism of Action in Human Gastric Cancer SGC7901/VCR Cells}},
  booktitle = {Evidence-based Complementary and Alternative Medicine},
  year = {2015},
  doi = {10.1155/2015/390812},
}
Figure